Investment Analysts’ price target changes for Monday, March 3rd:
American Airlines Group (NASDAQ:AAL) had its price target trimmed by JPMorgan Chase & Co. from $30.00 to $26.00. The firm currently has an overweight rating on the stock.
Acadia Healthcare (NASDAQ:ACHC) had its target price cut by KeyCorp from $70.00 to $65.00. KeyCorp currently has an overweight rating on the stock.
Adient (NYSE:ADNT) had its price target reduced by Morgan Stanley from $19.00 to $17.00. Morgan Stanley currently has an underweight rating on the stock.
Atlas Energy Solutions (NYSE:AESI) had its price target reduced by Barclays PLC from $23.00 to $19.00. Barclays PLC currently has an equal weight rating on the stock.
Akero Therapeutics (NASDAQ:AKRO) had its price target increased by HC Wainwright from $72.00 to $75.00. The firm currently has a buy rating on the stock.
Alamo Group (NYSE:ALG) had its price target reduced by DA Davidson from $219.00 to $217.00. They currently have a buy rating on the stock.
Alaska Air Group (NYSE:ALK) had its price target boosted by JPMorgan Chase & Co. from $85.00 to $89.00. The firm currently has an overweight rating on the stock.
Alkami Technology (NASDAQ:ALKT) had its target price reduced by Barclays PLC from $41.00 to $35.00. The firm currently has an equal weight rating on the stock.
Alkami Technology (NASDAQ:ALKT) had its price target lowered by The Goldman Sachs Group, Inc. from $39.00 to $32.00. They currently have a neutral rating on the stock.
Amneal Pharmaceuticals (NASDAQ:AMRX) had its target price boosted by Barclays PLC from $10.00 to $11.00. The firm currently has an overweight rating on the stock.
APA (NASDAQ:APA) had its price target trimmed by Susquehanna from $33.00 to $31.00. Susquehanna currently has a positive rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target lowered by Royal Bank of Canada from $26.00 to $25.00. They currently have a sector perform rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its price target cut by The Goldman Sachs Group, Inc. from $36.00 to $32.00. They currently have a neutral rating on the stock.
Apellis Pharmaceuticals (NASDAQ:APLS) had its target price cut by Wedbush from $30.00 to $29.00. Wedbush currently has a neutral rating on the stock.
Arhaus (NASDAQ:ARHS) had its target price trimmed by Stifel Nicolaus from $14.00 to $11.50. The firm currently has a buy rating on the stock.
Astrana Health (NASDAQ:ASTH) had its price target lowered by Robert W. Baird from $86.00 to $50.00. They currently have an outperform rating on the stock.
American Axle & Manufacturing (NYSE:AXL) had its target price lowered by Morgan Stanley from $10.00 to $8.00. Morgan Stanley currently has an overweight rating on the stock.
Axsome Therapeutics (NASDAQ:AXSM) had its price target raised by Robert W. Baird from $132.00 to $160.00. They currently have an outperform rating on the stock.
BAE Systems (LON:BA) had its target price raised by JPMorgan Chase & Co. from GBX 1,630 ($20.55) to GBX 1,725 ($21.74). JPMorgan Chase & Co. currently has an overweight rating on the stock.
Babcock International Group (LON:BAB) had its target price boosted by JPMorgan Chase & Co. from GBX 760 ($9.58) to GBX 900 ($11.35). The firm currently has an overweight rating on the stock.
Bath & Body Works (NYSE:BBWI) had its price target reduced by Barclays PLC from $43.00 to $38.00. They currently have an equal weight rating on the stock.
Bain Capital Specialty Finance (NYSE:BCSF) had its target price boosted by Wells Fargo & Company from $18.00 to $19.00. The firm currently has an overweight rating on the stock.
Beam Therapeutics (NASDAQ:BEAM) had its target price boosted by Scotiabank from $24.00 to $25.00. The firm currently has a sector perform rating on the stock.
BJ’s Wholesale Club (NYSE:BJ) had its target price boosted by JPMorgan Chase & Co. from $87.00 to $101.00. They currently have a neutral rating on the stock.
Bank of New York Mellon (NYSE:BK) had its price target boosted by Wells Fargo & Company from $86.00 to $96.00. The firm currently has an equal weight rating on the stock.
TopBuild (NYSE:BLD) had its price target trimmed by Benchmark Co. from $445.00 to $375.00. They currently have a buy rating on the stock.
Blend Labs (NYSE:BLND) had its target price cut by Keefe, Bruyette & Woods from $3.85 to $3.50. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
Boralex (TSE:BLX) had its target price reduced by Raymond James from C$41.00 to C$39.00.
BorgWarner (NYSE:BWA) had its target price trimmed by Morgan Stanley from $45.00 to $40.00. The firm currently has an overweight rating on the stock.
Cable One (NYSE:CABO) had its price target reduced by JPMorgan Chase & Co. from $420.00 to $325.00. The firm currently has a neutral rating on the stock.
CareDx (NASDAQ:CDNA) had its price target reduced by HC Wainwright from $26.00 to $25.00. They currently have a neutral rating on the stock.
Celldex Therapeutics (NASDAQ:CLDX) had its target price lowered by The Goldman Sachs Group, Inc. from $42.00 to $36.00. The firm currently has a neutral rating on the stock.
Clover Health Investments (NASDAQ:CLOV) had its target price increased by Canaccord Genuity Group Inc. from $4.20 to $4.50. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
Catalyst Pharmaceuticals (NASDAQ:CPRX) had its target price increased by Robert W. Baird from $28.00 to $32.00. The firm currently has an outperform rating on the stock.
CrowdStrike (NASDAQ:CRWD) had its target price increased by Canaccord Genuity Group Inc. from $370.00 to $420.00. They currently have a buy rating on the stock.
Chartwell Retirement Residences (TSE:CSH.UN) had its target price increased by CIBC from C$19.00 to C$20.00.
Chartwell Retirement Residences (TSE:CSH.UN) had its target price boosted by BMO Capital Markets from C$18.00 to C$19.00.
Chartwell Retirement Residences (TSE:CSH.UN) had its price target increased by TD Securities from C$19.00 to C$20.00. The firm currently has a buy rating on the stock.
CubeSmart (NYSE:CUBE) had its price target cut by Royal Bank of Canada from $53.00 to $48.00. Royal Bank of Canada currently has an outperform rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its target price boosted by Citigroup Inc. from $410.00 to $450.00. Citigroup Inc. currently has a buy rating on the stock.
Dell Technologies (NYSE:DELL) had its price target cut by The Goldman Sachs Group, Inc. from $165.00 to $145.00. They currently have a buy rating on the stock.
Definitive Healthcare (NASDAQ:DH) had its price target lowered by Barclays PLC from $4.00 to $3.00. Barclays PLC currently has an underweight rating on the stock.
DLocal (NASDAQ:DLO) had its price target reduced by Barclays PLC from $10.00 to $9.00. The firm currently has an equal weight rating on the stock.
Denali Therapeutics (NASDAQ:DNLI) had its target price cut by Oppenheimer Holdings Inc. from $50.00 to $42.00. They currently have an outperform rating on the stock.
Duolingo (NASDAQ:DUOL) had its target price boosted by The Goldman Sachs Group, Inc. from $275.00 to $340.00. They currently have a neutral rating on the stock.
Electronic Arts (NASDAQ:EA) had its target price boosted by Ascendiant Capital Markets from $157.00 to $160.00. Ascendiant Capital Markets currently has a buy rating on the stock.
eBay (NASDAQ:EBAY) had its price target boosted by Susquehanna from $60.00 to $65.00. They currently have a neutral rating on the stock.
Ecolab (NYSE:ECL) had its price target boosted by BMO Capital Markets from $295.00 to $305.00. They currently have an outperform rating on the stock.
Ecovyst (NYSE:ECVT) had its price target trimmed by BMO Capital Markets from $11.00 to $9.00. They currently have an outperform rating on the stock.
Ellington Financial (NYSE:EFC) had its price target boosted by Keefe, Bruyette & Woods from $13.75 to $14.50. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Edison International (NYSE:EIX) had its price target reduced by Barclays PLC from $67.00 to $65.00. Barclays PLC currently has an overweight rating on the stock.
Edison International (NYSE:EIX) had its price target trimmed by Mizuho from $75.00 to $66.00. Mizuho currently has an outperform rating on the stock.
EOG Resources (NYSE:EOG) had its price target reduced by Morgan Stanley from $143.00 to $142.00. They currently have an equal weight rating on the stock.
Equinix (NASDAQ:EQIX) had its price target increased by Scotiabank from $1,033.00 to $1,040.00. The firm currently has a sector outperform rating on the stock.
Embraer (NYSE:ERJ) had its target price raised by The Goldman Sachs Group, Inc. from $44.00 to $50.00. They currently have a buy rating on the stock.
Elastic (NYSE:ESTC) had its target price boosted by Truist Financial Co. from $135.00 to $145.00. The firm currently has a buy rating on the stock.
Eaton (NYSE:ETN) had its target price reduced by Barclays PLC from $353.00 to $325.00. The firm currently has an equal weight rating on the stock.
Extendicare (TSE:EXE) had its target price increased by BMO Capital Markets from C$11.00 to C$13.50.
Extendicare (TSE:EXE) had its target price raised by TD Securities from C$10.50 to C$13.00. TD Securities currently has a hold rating on the stock.
Expeditors International of Washington (NASDAQ:EXPD) had its target price raised by Susquehanna from $115.00 to $120.00. The firm currently has a neutral rating on the stock.
National Vision (NASDAQ:EYE) had its price target increased by Barclays PLC from $12.00 to $14.00. Barclays PLC currently has an equal weight rating on the stock.
First Advantage (NYSE:FA) had its price target cut by BMO Capital Markets from $24.00 to $22.00. The firm currently has an outperform rating on the stock.
4D Molecular Therapeutics (NASDAQ:FDMT) had its target price cut by Royal Bank of Canada from $39.00 to $35.00. They currently have an outperform rating on the stock.
FedEx (NYSE:FDX) had its price target cut by JPMorgan Chase & Co. from $372.00 to $323.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.
Foot Locker (NYSE:FL) had its price target trimmed by Evercore ISI from $30.00 to $22.00. The firm currently has an outperform rating on the stock.
FS KKR Capital (NYSE:FSK) had its target price boosted by Royal Bank of Canada from $21.00 to $22.00. Royal Bank of Canada currently has a sector perform rating on the stock.
FS KKR Capital (NYSE:FSK) had its target price increased by Keefe, Bruyette & Woods from $21.00 to $22.00. They currently have a market perform rating on the stock.
Frontdoor (NASDAQ:FTDR) had its price target trimmed by The Goldman Sachs Group, Inc. from $46.00 to $40.00. They currently have a sell rating on the stock.
TechnipFMC (NYSE:FTI) had its target price boosted by Barclays PLC from $42.00 to $43.00. They currently have an overweight rating on the stock.
FuboTV (NYSE:FUBO) had its price target raised by Needham & Company LLC from $2.00 to $3.50. They currently have a buy rating on the stock.
Green Dot (NYSE:GDOT) had its target price reduced by Barclays PLC from $10.00 to $7.00. They currently have an underweight rating on the stock.
Greif (NYSE:GEF) had its target price cut by Wells Fargo & Company from $76.00 to $75.00. They currently have an overweight rating on the stock.
GE Vernova (NYSE:GEV) had its target price reduced by BMO Capital Markets from $471.00 to $420.00. The firm currently has an outperform rating on the stock.
GE Vernova (NYSE:GEV) had its target price trimmed by Barclays PLC from $487.00 to $427.00. The firm currently has an overweight rating on the stock.
GitLab (NASDAQ:GTLB) had its price target trimmed by Robert W. Baird from $80.00 to $76.00. The firm currently has an outperform rating on the stock.
Chart Industries (NYSE:GTLS) had its price target cut by Wells Fargo & Company from $215.00 to $214.00. The firm currently has an overweight rating on the stock.
Chart Industries (NYSE:GTLS) had its price target boosted by TD Cowen from $205.00 to $210.00. The firm currently has a buy rating on the stock.
Hubbell (NYSE:HUBB) had its target price lowered by Barclays PLC from $475.00 to $422.00. They currently have an equal weight rating on the stock.
International Consolidated Airlines Group (LON:IAG) had its target price boosted by Barclays PLC from GBX 375 ($4.73) to GBX 420 ($5.29). Barclays PLC currently has an overweight rating on the stock.
Integral Ad Science (NASDAQ:IAS) had its target price raised by Morgan Stanley from $13.00 to $13.50. They currently have an equal weight rating on the stock.
Integral Ad Science (NASDAQ:IAS) had its price target increased by Truist Financial Co. from $16.00 to $17.00. They currently have a buy rating on the stock.
Installed Building Products (NYSE:IBP) had its target price cut by Benchmark Co. from $250.00 to $210.00. The firm currently has a buy rating on the stock.
Installed Building Products (NYSE:IBP) had its price target lowered by Truist Financial Co. from $240.00 to $180.00. The firm currently has a hold rating on the stock.
IDACORP (NYSE:IDA) had its target price raised by Bank of America Co. from $119.00 to $127.00. The firm currently has a buy rating on the stock.
International Money Express (NASDAQ:IMXI) had its price target reduced by Needham & Company LLC from $25.00 to $20.00. They currently have a buy rating on the stock.
Intuit (NASDAQ:INTU) had its price target raised by Mizuho from $750.00 to $765.00. They currently have an outperform rating on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its target price trimmed by Truist Financial Co. from $25.00 to $15.00. Truist Financial Co. currently has a buy rating on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its price target reduced by The Goldman Sachs Group, Inc. from $22.00 to $19.00. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Iovance Biotherapeutics (NASDAQ:IOVA) had its target price lowered by Chardan Capital from $34.00 to $30.00. They currently have a buy rating on the stock.
Disc Medicine (NASDAQ:IRON) had its target price increased by Scotiabank from $73.00 to $75.00. They currently have a sector outperform rating on the stock.
Nextdoor (NYSE:KIND) had its target price lowered by The Goldman Sachs Group, Inc. from $3.00 to $2.50. They currently have a neutral rating on the stock.
Kinder Morgan (NYSE:KMI) had its target price increased by Royal Bank of Canada from $26.00 to $27.00. The firm currently has a sector perform rating on the stock.
Karyopharm Therapeutics (NASDAQ:KPTI) had its target price reduced by Robert W. Baird from $75.00 to $54.00. The firm currently has an outperform rating on the stock.
Laurentian Bank of Canada (TSE:LB) had its price target cut by Raymond James from C$29.00 to C$27.00.
Laurentian Bank of Canada (TSE:LB) had its price target lowered by BMO Capital Markets from C$31.00 to C$30.00.
Lear (NYSE:LEA) had its target price lowered by Morgan Stanley from $135.00 to $125.00. Morgan Stanley currently has an overweight rating on the stock.
Leslie’s (NASDAQ:LESL) had its price target cut by Morgan Stanley from $3.00 to $1.50. The firm currently has an equal weight rating on the stock.
LivaNova (NASDAQ:LIVN) had its price target cut by The Goldman Sachs Group, Inc. from $64.00 to $55.00. They currently have a buy rating on the stock.
Landsea Homes (NASDAQ:LSEA) had its target price reduced by Barclays PLC from $9.00 to $7.00. They currently have an equal weight rating on the stock.
Life Time Group (NYSE:LTH) had its price target increased by The Goldman Sachs Group, Inc. from $22.00 to $32.00. They currently have a neutral rating on the stock.
Main Street Capital (NYSE:MAIN) had its target price raised by Truist Financial Co. from $52.00 to $62.00. The firm currently has a hold rating on the stock.
MARA (NASDAQ:MARA) had its price target reduced by Barclays PLC from $27.00 to $14.00. Barclays PLC currently has an equal weight rating on the stock.
MARA (NASDAQ:MARA) had its target price cut by Piper Sandler from $34.00 to $30.00. Piper Sandler currently has an overweight rating on the stock.
MongoDB (NASDAQ:MDB) had its price target trimmed by Loop Capital from $400.00 to $350.00. Loop Capital currently has a buy rating on the stock.
MercadoLibre (NASDAQ:MELI) had its price target boosted by The Goldman Sachs Group, Inc. from $2,400.00 to $2,750.00. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Magna International (NYSE:MGA) (TSE:MG) had its target price lowered by Morgan Stanley from $43.00 to $40.00. The firm currently has an equal weight rating on the stock.
Monster Beverage (NASDAQ:MNST) had its target price raised by UBS Group AG from $53.00 to $57.00. The firm currently has a neutral rating on the stock.
Molina Healthcare (NYSE:MOH) had its price target lowered by Mizuho from $382.00 to $376.00. The firm currently has an outperform rating on the stock.
Morningstar (NASDAQ:MORN) had its price target cut by BMO Capital Markets from $387.00 to $370.00. The firm currently has an outperform rating on the stock.
Mosaic (NYSE:MOS) had its target price trimmed by Scotiabank from $34.00 to $31.00. Scotiabank currently has a sector outperform rating on the stock.
Mosaic (NYSE:MOS) had its price target lowered by Mizuho from $29.00 to $28.00. The firm currently has a neutral rating on the stock.
Maravai LifeSciences (NASDAQ:MRVI) had its target price lowered by Bank of America Co. from $9.00 to $8.00. They currently have a buy rating on the stock.
Morgan Stanley Direct Lending (NYSE:MSDL) had its target price cut by Wells Fargo & Company from $21.00 to $20.00. They currently have an equal weight rating on the stock.
MasTec (NYSE:MTZ) had its target price trimmed by Robert W. Baird from $162.00 to $153.00. They currently have a neutral rating on the stock.
MasTec (NYSE:MTZ) had its price target increased by Citigroup Inc. from $156.00 to $167.00. The firm currently has a buy rating on the stock.
MasTec (NYSE:MTZ) had its target price cut by Stifel Nicolaus from $185.00 to $175.00. They currently have a buy rating on the stock.
MVB Financial (NASDAQ:MVBF) had its target price lowered by Keefe, Bruyette & Woods from $26.00 to $25.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Myriad Genetics (NASDAQ:MYGN) had its target price cut by Bank of America Co. from $13.00 to $11.00. They currently have an underperform rating on the stock.
N-able (NYSE:NABL) had its price target cut by Needham & Company LLC from $16.50 to $10.00. Needham & Company LLC currently has a buy rating on the stock.
Novanta (NASDAQ:NOVT) had its price target lowered by Robert W. Baird from $169.00 to $160.00. Robert W. Baird currently has a neutral rating on the stock.
Nerdy (NYSE:NRDY) had its price target increased by The Goldman Sachs Group, Inc. from $1.00 to $1.50. The firm currently has a neutral rating on the stock.
NexPoint Real Estate Finance (NYSE:NREF) had its target price raised by Keefe, Bruyette & Woods from $15.50 to $16.00. They currently have a market perform rating on the stock.
NRG Energy (NYSE:NRG) had its price target boosted by BMO Capital Markets from $100.00 to $115.00. They currently have a market perform rating on the stock.
nVent Electric (NYSE:NVT) had its target price cut by Barclays PLC from $88.00 to $83.00. They currently have an overweight rating on the stock.
Owens & Minor (NYSE:OMI) had its price target boosted by Robert W. Baird from $10.00 to $11.00. Robert W. Baird currently has a neutral rating on the stock.
Public Service Enterprise Group (NYSE:PEG) had its price target lowered by Bank of America Co. from $95.00 to $92.00. Bank of America Co. currently has a buy rating on the stock.
PENN Entertainment (NASDAQ:PENN) had its price target raised by Wells Fargo & Company from $20.00 to $24.00. The firm currently has an equal weight rating on the stock.
Pembina Pipeline (TSE:PPL) (NYSE:PBA) had its price target boosted by Raymond James from C$62.00 to C$63.00.
Praxis Precision Medicines (NASDAQ:PRAX) had its target price trimmed by Robert W. Baird from $117.00 to $73.00. Robert W. Baird currently has an outperform rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its target price trimmed by Needham & Company LLC from $150.00 to $85.00. They currently have a buy rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its target price reduced by HC Wainwright from $120.00 to $105.00. HC Wainwright currently has a buy rating on the stock.
Praxis Precision Medicines (NASDAQ:PRAX) had its price target trimmed by Truist Financial Co. from $175.00 to $85.00. Truist Financial Co. currently has a buy rating on the stock.
Porch Group (NASDAQ:PRCH) had its target price raised by Keefe, Bruyette & Woods from $3.50 to $6.00. They currently have a market perform rating on the stock.
ProPetro (NYSE:PUMP) had its target price trimmed by Barclays PLC from $12.00 to $11.00. The firm currently has an overweight rating on the stock.
QinetiQ Group (LON:QQ) had its price target increased by Barclays PLC from GBX 535 ($6.74) to GBX 570 ($7.19). The firm currently has an overweight rating on the stock.
Rocket Pharmaceuticals (NASDAQ:RCKT) had its price target increased by Scotiabank from $51.00 to $52.00. They currently have a sector outperform rating on the stock.
Rocket Pharmaceuticals (NASDAQ:RCKT) had its price target trimmed by The Goldman Sachs Group, Inc. from $29.00 to $15.00. The firm currently has a neutral rating on the stock.
Rocket Pharmaceuticals (NASDAQ:RCKT) had its price target cut by Canaccord Genuity Group Inc. from $39.00 to $36.00. They currently have a buy rating on the stock.
Redfin (NASDAQ:RDFN) had its target price reduced by JPMorgan Chase & Co. from $8.00 to $7.00. The firm currently has a neutral rating on the stock.
Redfin (NASDAQ:RDFN) had its target price trimmed by Susquehanna from $10.00 to $7.00. They currently have a neutral rating on the stock.
Rocket Lab USA (NASDAQ:RKLB) had its target price cut by Wells Fargo & Company from $22.00 to $21.00. They currently have an equal weight rating on the stock.
Rocket Companies (NYSE:RKT) had its price target raised by Keefe, Bruyette & Woods from $10.50 to $12.00. The firm currently has an underperform rating on the stock.
Sunrun (NASDAQ:RUN) had its price target reduced by The Goldman Sachs Group, Inc. from $17.00 to $15.00. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Sunrun (NASDAQ:RUN) had its price target reduced by BMO Capital Markets from $11.00 to $9.00. They currently have a market perform rating on the stock.
Sunrun (NASDAQ:RUN) had its target price reduced by Royal Bank of Canada from $17.00 to $14.00. Royal Bank of Canada currently has an outperform rating on the stock.
Revolution Medicines (NASDAQ:RVMD) had its price target boosted by HC Wainwright from $72.00 to $73.00. HC Wainwright currently has a buy rating on the stock.
Rhythm Pharmaceuticals (NASDAQ:RYTM) had its price target raised by HC Wainwright from $69.00 to $70.00. HC Wainwright currently has a buy rating on the stock.
Seacoast Banking Co. of Florida (NASDAQ:SBCF) had its price target increased by Stephens from $28.00 to $29.00. They currently have an equal weight rating on the stock.
Stella-Jones (TSE:SJ) had its target price trimmed by Scotiabank from C$85.00 to C$79.00.
J. M. Smucker (NYSE:SJM) had its target price lowered by Barclays PLC from $123.00 to $119.00. They currently have an equal weight rating on the stock.
Solventum (NYSE:SOLV) had its price target raised by Mizuho from $70.00 to $82.00. They currently have a neutral rating on the stock.
Solventum (NYSE:SOLV) had its target price increased by The Goldman Sachs Group, Inc. from $63.00 to $71.00. They currently have a sell rating on the stock.
Virgin Galactic (NYSE:SPCE) had its price target trimmed by The Goldman Sachs Group, Inc. from $41.00 to $36.00. The firm currently has a neutral rating on the stock.
Strategic Education (NASDAQ:STRA) had its price target trimmed by BMO Capital Markets from $114.00 to $97.00. The firm currently has an outperform rating on the stock.
AT&T (NYSE:T) had its target price increased by Scotiabank from $26.00 to $28.50. They currently have a sector outperform rating on the stock.
Teladoc Health (NYSE:TDOC) had its target price reduced by The Goldman Sachs Group, Inc. from $16.00 to $13.00. They currently have a buy rating on the stock.
Tempus AI (NASDAQ:TEM) had its price target boosted by Bank of America Co. from $54.00 to $60.00. The firm currently has a neutral rating on the stock.
Timbercreek Financial (TSE:TF) had its price target trimmed by TD Securities from C$8.00 to C$7.00. The firm currently has a hold rating on the stock.
TFI International (NYSE:TFII) had its target price lowered by Susquehanna from $170.00 to $135.00. Susquehanna currently has a positive rating on the stock.
Teleflex (NYSE:TFX) had its price target lowered by Truist Financial Co. from $200.00 to $149.00. Truist Financial Co. currently has a hold rating on the stock.
Treace Medical Concepts (NASDAQ:TMCI) had its target price increased by Truist Financial Co. from $8.40 to $10.00. They currently have a hold rating on the stock.
T-Mobile US (NASDAQ:TMUS) had its price target increased by Scotiabank from $247.00 to $275.00. Scotiabank currently has a sector perform rating on the stock.
Tandem Diabetes Care (NASDAQ:TNDM) had its price target reduced by The Goldman Sachs Group, Inc. from $42.00 to $24.00. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Targa Resources (NYSE:TRGP) had its target price boosted by Royal Bank of Canada from $220.00 to $221.00. They currently have an outperform rating on the stock.
Trinity Industries (NYSE:TRN) had its price target raised by Susquehanna from $34.00 to $35.00. Susquehanna currently has a neutral rating on the stock.
TTEC (NASDAQ:TTEC) had its target price trimmed by Canaccord Genuity Group Inc. from $4.50 to $3.50. They currently have a hold rating on the stock.
Take-Two Interactive Software (NASDAQ:TTWO) had its target price boosted by Ascendiant Capital Markets from $172.00 to $270.00. They currently have a buy rating on the stock.
TXNM Energy (NYSE:TXNM) had its price target raised by Mizuho from $50.00 to $53.00. Mizuho currently has a neutral rating on the stock.
Unum Group (NYSE:UNM) had its target price raised by BMO Capital Markets from $95.00 to $102.00. BMO Capital Markets currently has an outperform rating on the stock.
Visteon (NASDAQ:VC) had its price target reduced by Barclays PLC from $115.00 to $110.00. They currently have an overweight rating on the stock.
Visteon (NASDAQ:VC) had its target price trimmed by Morgan Stanley from $100.00 to $95.00. Morgan Stanley currently has an equal weight rating on the stock.
VEON (NASDAQ:VEON) had its price target boosted by Benchmark Co. from $48.00 to $56.00. Benchmark Co. currently has a buy rating on the stock.
Vertex (NASDAQ:VERX) had its price target trimmed by The Goldman Sachs Group, Inc. from $64.00 to $48.00. The firm currently has a buy rating on the stock.
Vertiv (NYSE:VRT) had its target price lowered by Barclays PLC from $131.00 to $111.00. They currently have an equal weight rating on the stock.
Verizon Communications (NYSE:VZ) had its target price raised by Scotiabank from $47.50 to $48.00. They currently have a sector perform rating on the stock.
Receive News & Ratings for American Airlines Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Airlines Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.
